CTMX stock icon

CytomX Therapeutics
CTMX

$1.28
0.78%
 

About: CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Employees: 122

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 7 analysts
0
News positive %
of 5 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

3,430% more call options, than puts

Call options by funds: $353K | Put options by funds: $10K

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

91% more capital invested

Capital invested by funds: $50.6M [Q4 2023] → $96.6M (+$46M) [Q1 2024]

28% more funds holding

Funds holding: 68 [Q4 2023] → 87 (+19) [Q1 2024]

16.69% more ownership

Funds ownership: 48.73% [Q4 2023] → 65.42% (+16.69%) [Q1 2024]

21% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 24

Research analyst outlook

7 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$3
134%
upside
Avg. target
$4.66
264%
upside
High target
$8
525%
upside

7 analyst ratings

positive
43%
neutral
57%
negative
0%
Piper Sandler
Joseph Catanzaro
173%upside
$3.5
Overweight
Upgraded
28 May 2024
BMO Capital
Etzer Darout
180%upside
$3.59
Market Perform
Maintained
9 May 2024
Wedbush
Robert Driscoll
525%upside
$8
Outperform
Upgraded
9 May 2024
Jefferies
Roger Song
525%upside
$8
Buy
Upgraded
6 May 2024
BMO Capital
Etzer Darout
154%upside
$3.25
Market Perform
Reiterated
1 May 2024

Financial journalist opinion

Based on 5 articles about CTMX published over the past 30 days